<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>Inpatient Antibiotic Guide</title>
<style>
body { font-family: Arial, sans-serif; margin:0; padding:0; display:flex; }
#sidebar { width:220px; background:#f8f8f8; padding:10px; border-right:1px solid #ccc; height:100vh; overflow-y:auto; }
#sidebar h2 { margin-top:0; }
#sidebar ul { list-style:none; padding-left:0; }
#sidebar li { margin:5px 0; cursor:pointer; color:#007BFF; }
#content { flex:1; padding:20px; overflow-y:auto; }
.expandable { background:#e2e2e2; padding:10px; margin:5px 0; cursor:pointer; border-radius:4px; }
.hidden { display:none; }
table { width:100%; border-collapse:collapse; margin:10px 0; }
th, td { border:1px solid #ccc; padding:5px; text-align:left; }
th { background:#f0f0f0; }
.firstline { background:#fff; }
.alternative { background:#f9f9f9; }
</style>
<script>
function showContent(id){
    var sections = document.querySelectorAll('#content > div');
    sections.forEach(s=>s.style.display='none');
    var section = document.getElementById(id);
    if(section) section.style.display='block';
}
function toggleVisibility(id){
    var e = document.getElementById(id);
    if(e) e.style.display = (e.style.display === 'block') ? 'none' : 'block';
}
</script>
</head>
<body>

<div id="sidebar">
  <h2>Sections</h2>
  <ul>
    <li onclick="showContent('homepage')">Home</li>
    <li onclick="showContent('cap')">Community-Acquired Pneumonia</li>
    <li onclick="showContent('hap')">Hospital-Acquired Pneumonia</li>
    <li onclick="showContent('uti')">Urinary Tract Infection</li>
    <li onclick="showContent('ssi')">Skin & Soft Tissue Infection</li>
    <li onclick="showContent('iai')">Intra-Abdominal Infection</li>
    <li onclick="showContent('cns')">CNS Infection</li>
    <li onclick="showContent('endocarditis')">Endocarditis</li>
    <li onclick="showContent('pathogen')">Pathogen-Based Guidance</li>
    <li onclick="showContent('classes')">Antibiotic Classes / Escalation</li>
    <li onclick="showContent('references')">References</li>
  </ul>
</div>

<div id="content">

<!-- Homepage -->
<div id="homepage">
  <div style="text-align:center; margin-top:50px;">
    <img src="mutant-icon.png" alt="Mutant Icon" style="width:150px; height:150px; margin-bottom:20px;">
    <h1>Welcome to the Inpatient Antibiotic Guide</h1>
    <p>Select a section from the sidebar to view empiric therapy, Gram-stain guidance, culture-directed therapy, or pathogen-based escalation guidance.</p>
  </div>
</div>

<!-- CAP -->
<div id="cap" style="display:none;">
<h2>Community-Acquired Pneumonia (CAP)</h2>
<h3>Empiric Therapy</h3>
<table>
<tr><th>Severity</th><th>Empiric Therapy</th><th>Duration</th><th>Notes</th></tr>
<tr>
<td>Outpatient, no comorbidities</td>
<td>Amoxicillin 1 g PO TID OR Doxycycline 100 mg PO BID OR Macrolide (if local resistance <25%)</td>
<td>5 days</td>
<td>-</td>
</tr>
<tr>
<td>Outpatient, comorbidities</td>
<td>Amox/Clav 875/125 mg PO BID OR Cephalosporin + Macrolide OR Respiratory FQ</td>
<td>5–7 days</td>
<td>Check allergies and local resistance</td>
</tr>
<tr>
<td>Inpatient, non-ICU</td>
<td>Ceftriaxone 1–2 g IV q24h + Azithromycin 500 mg IV/PO day1, then 250 mg daily</td>
<td>5–7 days</td>
<td>Consider respiratory FQ if contraindications</td>
</tr>
<tr>
<td>ICU</td>
<td>Ceftriaxone + Azithromycin IV</td>
<td>7–10 days</td>
<td>Add MRSA or Pseudomonas coverage if risk factors</td>
</tr>
</table>

<h3>Culture-Directed Therapy</h3>
<table>
<tr><th>Organism</th><th>Drug</th><th>Dosing</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Streptococcus pneumoniae (penicillin susceptible)</td><td>Penicillin G IV</td><td>2–4 M units IV q4–6h</td><td>7–10 days</td><td>Adjust per renal function</td></tr>
<tr><td>MRSA</td><td>Vancomycin IV</td><td>15 mg/kg IV q12h (monitor trough)</td><td>7–14 days</td><td>Linezolid 600 mg IV/PO q12h alternative</td></tr>
<tr><td>Pseudomonas aeruginosa</td><td>Cefepime IV</td><td>2 g IV q8h</td><td>7–10 days</td><td>Combination therapy if critically ill</td></tr>
</table>
</div>

<!-- HAP -->
<div id="hap" style="display:none;">
<h2>Hospital-Acquired Pneumonia (HAP)</h2>
<h3>Empiric Therapy</h3>
<table>
<tr><th>Risk Factor</th><th>Empiric Therapy</th><th>Duration</th><th>Notes</th></tr>
<tr><td>No MRSA or high-risk Gram-neg</td><td>Piperacillin-Tazobactam 4.5 g IV q6h OR Cefepime 2 g IV q8h OR Imipenem 1 g IV q6h</td><td>7–8 days</td><td>Adjust renal function</td></tr>
<tr><td>Risk MRSA</td><td>Add Vancomycin IV or Linezolid IV/PO</td><td>7–14 days</td><td>Monitor drug levels</td></tr>
<tr><td>High-risk MDR Gram-neg</td><td>Dual anti-pseudomonal therapy</td><td>7–14 days</td><td>Use culture-directed escalation</td></tr>
</table>
</div>

<!-- UTI -->
<div id="uti" style="display:none;">
<h2>Urinary Tract Infection (UTI)</h2>
<h3>Empiric Therapy</h3>
<table>
<tr><th>Setting</th><th>Drug</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Outpatient, uncomplicated</td><td>Nitrofurantoin 100 mg PO BID x5d OR TMP-SMX 160/800 mg PO BID x3d</td><td>3–5 days</td><td>Avoid TMP-SMX if resistance>20%</td></tr>
<tr><td>Inpatient, complicated</td><td>Ceftriaxone IV 1 g q24h OR Piperacillin-Tazobactam IV 4.5 g q6h</td><td>7–10 days</td><td>Adjust renal function</td></tr>
</table>
</div>

<!-- SSI -->
<div id="ssi" style="display:none;">
<h2>Skin & Soft Tissue Infection (SSI)</h2>
<h3>Empiric Therapy</h3>
<table>
<tr><th>Type</th><th>Drug</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Mild outpatient</td><td>Cephalexin 500 mg PO q6h OR Dicloxacillin 500 mg PO q6h</td><td>5–7 days</td><td>-</td></tr>
<tr><td>Severe inpatient</td><td>Vancomycin IV 15 mg/kg q12h ± Piperacillin-Tazobactam IV 4.5 g q6h</td><td>7–14 days</td><td>Adjust per renal function</td></tr>
</table>
</div>

<!-- IAI -->
<div id="iai" style="display:none;">
<h2>Intra-Abdominal Infection (IAI)</h2>
<h3>Empiric Therapy</h3>
<table>
<tr><th>Severity</th><th>Drug</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Mild-moderate CA</td><td>Ceftriaxone IV + Metronidazole IV</td><td>4–7 days</td><td>-</td></tr>
<tr><td>Severe / HA</td><td>Piperacillin-Tazobactam IV 4.5 g q6h OR Meropenem IV 1 g q8h</td><td>7–10 days</td><td>-</td></tr>
</table>
</div>

<!-- CNS -->
<div id="cns" style="display:none;">
<h2>CNS Infection</h2>
<h3>Empiric Therapy</h3>
<table>
<tr><th>Scenario</th><th>Drug</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Bacterial meningitis, adult</td><td>Ceftriaxone 2 g IV q12h + Vancomycin IV 15 mg/kg q12h ± Dexamethasone</td><td>7–14 days</td><td>Add Ampicillin 2 g q4h if Listeria risk</td></tr>
</table>
</div>

<!-- Endocarditis -->
<div id="endocarditis" style="display:none;">
<h2>Endocarditis</h2>
<h3>Empiric Therapy (native valve, non-IVDU)</h3>
<table>
<tr><th>Drug</th><th>Dosing</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Vancomycin IV</td><td>15 mg/kg q12h, target trough 15–20 mcg/mL</td><td>4–6 weeks</td><td>-</td></tr>
<tr><td>Gentamicin IV (optional synergy)</td><td>1 mg/kg q8h, monitor renal</td><td>2 weeks (synergy only)</td><td>-</td></tr>
</table>
</div>

<!-- Pathogen-Based Guidance -->
<div id="pathogen" style="display:none;">
<h2>Pathogen-Based Guidance</h2>
<p>Insert full expandable tables here for each genus including Mycobacterium, Corynebacterium, Nocardia, Streptococcus, Prevotella, Staphylococcus, Clostridium, Bacteroides, Actinomyces, Burkholderia.</p>
<!-- Ensure each table includes Duration column -->
</div>

<!-- Antibiotic Classes / Escalation -->
<div id="classes" style="display:none;">
<h2>Antibiotic Classes / Escalation</h2>
<p>Insert class, coverage, dosing, route, renal adjustments, and escalation hierarchy.</p>
</div>

<!-- References -->
<div id="references" style="display:none;">
<h2>References</h2>
<ul>
<li>IDSA Guidelines 2016, 2018, 2019, 2020</li>
<li>Harrison's Principles of Internal Medicine, 20th Edition</li>
<li>NEJM and JAMA relevant articles</li>
</ul>
</div>

</div>
</body>
</html>
